HAO - Haoxi Health Technol... Stock Analysis | Stock Taper
Logo
Haoxi Health Technology Limited

HAO

Haoxi Health Technology Limited NASDAQ
$1.05 2.94% (+0.03)

Market Cap $61548
52w High $285.44
52w Low $0.78
P/E -0.06
Volume 237.22K
Outstanding Shares 58.62K

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2026 $33.83M $7.28M $-6.88M -20.34% $-1.53 $-5.42M
Q4-2025 $8.85M $2.32M $4.11M 46.44% $1.42 $4.2M
Q2-2025 $23.95M $607.74K $-232.53K -0.97% $-0.01 $11.61K
Q4-2024 $25.02M $650.11K $529.8K 2.12% $0.04 $959.42K
Q2-2024 $23.5M $383.02K $760.2K 3.23% $0.06 $829.96K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2026 $6.8M $20.66M $4.7M $15.96M
Q4-2025 $8.62M $21.6M $4.22M $17.38M
Q2-2025 $9.1M $22.07M $3.32M $18.74M
Q4-2024 $6.66M $15.51M $4.23M $11.27M
Q2-2024 $1.11M $6.17M $4.45M $1.72M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2026 $-6.88M $-2.27M $-4.5M $4.93M $-1.82M $-2.27M
Q4-2025 $4.11M $-1.11M $-505.18K $1.16M $-477.96K $-1.1M
Q2-2025 $-232.53K $-2.25M $-3.07M $7.75M $2.44M $-2.26M
Q4-2024 $531.47K $-1.05M $-3.11M $9.08M $5.54M $-1.09M
Q2-2024 $760.2K $301K $-16.16K $239.4K $1.11M $284.84K

5-Year Trend Analysis

A comprehensive look at Haoxi Health Technology Limited's financial evolution and strategic trajectory over the past five years.

+ Strengths

The company has several notable positives: a transformed balance sheet with strong cash reserves and low leverage; a clear niche focus in healthcare digital advertising; proprietary technology and established platform relationships; and a track record of rapid historical growth and improving reported earnings through 2024. Its asset-light model and strong liquidity give it flexibility to experiment with new services such as livestreaming without immediate financing stress.

! Risks

The most significant risks center on operations and cash. Revenue has become volatile, with a sharp drop in the latest year. Operating profit has turned negative, overhead has surged, and gross profits have come under pressure, pointing to execution or demand challenges. Cash flow from operations and free cash flow have been negative for several years, leaving the company reliant on equity financing. In addition, regulatory uncertainty in healthcare advertising, intense competition, and the need to continually refresh technology all add to the risk profile.

Outlook

The outlook is mixed and uncertain. On one hand, Haoxi sits in a growing structural niche with differentiated capabilities, a strong liquidity cushion, and promising innovation in tools and livestreaming services. On the other, the current business model is not yet generating reliable operating profits or cash, and recent financial trends have moved in the wrong direction. Future performance will depend on the company’s ability to stabilize revenue, rein in costs, convert its specialized offerings into recurring, high-quality business, and turn accounting profits into sustainable cash flows.